Brevan Howard Capital Management LP Vaxcyte, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 1,847 shares of PCVX stock, worth $163,127. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,847Holding current value
$163,127% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PCVX
# of Institutions
357Shares Held
123MCall Options Held
772KPut Options Held
430K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.01 Billion0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$965 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$878 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$767 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$433 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.24B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...